{{Rsnum
|rsid=17318866
|Chromosome=6
|position=3836964
|Orientation=plus
|GMAF=0.2576
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 14.2 | 48.7 | 37.2
| HCB | 7.3 | 36.5 | 56.2
| JPT | 5.3 | 31.9 | 62.8
| YRI | 1.4 | 18.4 | 80.3
| ASW | 5.3 | 26.3 | 68.4
| CHB | 7.3 | 36.5 | 56.2
| CHD | 8.3 | 35.8 | 56.0
| GIH | 4.0 | 46.5 | 49.5
| LWK | 1.8 | 20.0 | 78.2
| MEX | 6.9 | 34.5 | 58.6
| MKK | 0.0 | 18.6 | 81.4
| TSI | 9.8 | 58.8 | 31.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=G
  |Pval=1E-6
  |OR=7.56
  |ORtxt=[2.689-21.263]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}